Indeed, the elevated mutational burden and expression of cytotoxic T cells, NK cell infiltration, Th1 lymphocytes, and PD-1 due to enhanced neoantigens are hallmarks of the CMS1 subtype of CRC [221] (see Figure 5). The gene discussed is PDCD1; the disease is colorectal carcinoma.